TITLE

Too heavy to save or be saved

AUTHOR(S)
Freedhoff, Yoni
PUB. DATE
September 2011
SOURCE
CMAJ: Canadian Medical Association Journal;9/20/2011, Vol. 183 Issue 13, pE975
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses two cases in which overweight persons could not save lives or be saved because of their weight. It states that Ian Patton was not able to donate stem cells as his weight of around 147.7 kilograms (kg) prevent him from doing so. It says that mother Kim Aziz who has end-stage renal disease (ESRD) was not accepted by Ottawa Hospital's renal transplant team in Ontario for surgery unless she trimmed her weight.
ACCESSION #
66291611

 

Related Articles

  • His Kidney Donation May Save Student.  // Current Events;12/17/2007, Vol. 107 Issue 13, p6 

    The article focuses on donation of kidney by Jim Friel, principal at Franklin Middle School to Morgan Corliss, the New Hampshire eighth grader at this school. Corliss reportedly suffered from kidney disease that interfered with kidney function and made it tough for her to play basketball for...

  • Plerixafor 'just in time' for stem cell mobilization in a normal donor. Schriber, J.; Fauble, V.; Sproat, L. O.; Briggs, A. // Bone Marrow Transplantation;Jul2011, Vol. 46 Issue 7, p1026 

    A letter to the editor is presented regarding the use of plerixafor in the mobilization of stem cells for transplantation using the so-called just in time rescue strategy on a 56-year-old normal donor.

  • Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Kozuka, T; Ishimaru, F; Fujii, K; Masuda, K; Kaneda, K; Imai, T; Fujii, N; Ishikura, H; Hongo, S; Watanabe, T; Shinagawa, K; Ikeda, K; Niiya, K; Harada, M; Tanimoto, M // Bone Marrow Transplantation;Apr2003, Vol. 31 Issue 8, p651 

    Summary:In this report, we examined plasma stromal cell-derived factor-1 levels in normal healthy donors for allogeneic peripheral blood stem cell transplantation (PBSCT) and in patients for autologous PBSCT using an enzyme-linked immunosorbent assay. The average level of plasma stromal...

  • Five things to know about . . . Donation and transplantation of allogeneic hematopoietic stem cells. Kopolovic, Ilana; Turner, Robert // CMAJ: Canadian Medical Association Journal;11/22/2011, Vol. 183 Issue 17, p2014 

    The article presents five things to know regarding allogeneic hematopoietic stem cells donation and transplantation in Canada. It states that only 30% of Canadian patients with indications for an allogeneic stem cell transplant have a matched related donor, while 70% seek an unrelated donor on...

  • Hematopoietic stem cell donor registry strategies for assigning search determinants and matching relationships. Hurley, C. K.; Setterholm, M.; Lau, M.; Pollack, M. S.; Noreen, H.; Howard, A.; Fernandez-Vina, M.; Kukuruga, D.; Müller, C. R.; Venance, M.; Wade, J. A.; Oudshoorn, M.; Raffoux, C.; Enczmann, J.; Wernet, P.; Maiers, M. // Bone Marrow Transplantation;Feb2004, Vol. 33 Issue 4, p443 

    Summary:Registries and cord blood banks around the world collect and store the HLA types of volunteers in order to identify matched unrelated donors for patients requiring hematopoietic stem cell transplantation. This task is complicated by the many formats in which HLA types are provided by the...

  • Chronology of renal scarring in males with Alport syndrome. Kashtan, Clifford E.; Gubler, Marie-Claire; Sisson-Ross, Susan; Mauer, Michael // Pediatric Nephrology;1998, Vol. 12 Issue 4, p269 

    We investigated the onset of renal scarring in 62 males (aged 4-26 years) with Alport syndrome by measuring cortical interstitial volume fraction [Vv (interstitium/cortex)] and percentage global glomerular sclerosis in kidney biopsies. Male pediatric (n = 9) and adult (n = 7) donor kidneys...

  • Anti-HBc Ab(+) renal allografts should be considered for donation. Fong, T.-L.; Bunnapradist, S.; Jordan, S. C. // Kidney;Jul/Aug2002, Vol. 11 Issue 4, p171 

    Deals with a study which aimed to determine the effects of anti-HBc AB(+) donor status on viral transmission and graft and patient survival. Methodology used in the study; Results and conclusion.

  • Obese Donors Not At Higher Renal Risk. Charnow, Jody A. // Renal & Urology News;Jun2011, Vol. 10 Issue 6, p1 

    The article focuses on a study by a research team led by Raj Amin and Andrew M. Posselt of University of California in San Francisco regarding the associated risk factors in obese kidney donors. The study examined 146 kidney donors according to their body mass index (BMI) including normal...

  • Unusual complication of percutaneous nephrostomy in a renal transplant recipient. Nitschke, Martin; Paetzel, Martina; Haas, Christian S. // North American Journal of Medical Sciences;Nov2010, Vol. 2 Issue 11, p537 

    Context: Ureteral obstruction, resulting in impaired graft function, is a well-known problem following renal transplantation. Management of ureteral complications includes percutaneous nephrostomy, which is considered to be a safe and effective measure. Case Report: Here, we demonstrate a case...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics